Fidelity D&D Bancorp’s Pfizer PFE Stock Holding History

Fidelity D&D Bancorp’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,486	Closed	-$248K	–	107
2023 Q3	$248K	Buy	+7,486	New	+$265K	0.26%	76

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity D&D Bancorp's PFE Position: Q4 2023 in Review

Fidelity D&D Bancorp sold out of Pfizer (PFE) in Q4 2023, closing a stake of 7,486 shares — an estimated $248K sold.

Fidelity D&D Bancorp first reported a position in PFE in Q3 2023 and held it in 1 quarter. The position peaked at $248K in Q3 2023. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Fidelity D&D Bancorp reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Fidelity D&D Bancorp sold 7,486 Pfizer shares in Q4 2023, an estimated $248K.
Fidelity D&D Bancorp first reported a position in Pfizer in Q3 2023 and held it in 1 quarter.
Fidelity D&D Bancorp's Pfizer position peaked at $248K in Q3 2023.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Fidelity D&D Bancorp's 13F filing for Q4 2023, filed 12 Jan 2024.